| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | 2.877 |
| Total Income - EUR | - | - | 0 | 0 | 0 | 2.792 | 22.972 | 0 | - | 29.740 |
| Total Expenses - EUR | - | - | 0 | 33 | 51.456 | 1.398 | 10.626 | 47.794 | - | 35.548 |
| Gross Profit/Loss - EUR | - | - | 0 | -33 | -51.456 | 1.394 | 12.346 | -47.794 | - | -5.809 |
| Net Profit/Loss - EUR | - | - | 0 | -33 | -51.456 | 1.394 | 12.346 | -47.794 | - | -5.809 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
Check the financial reports for the company - Afine Biofruct Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 303.525 | 473.311 | 444.086 | - | 382.973 |
| Current Assets | - | - | 44 | 30.965 | 564.654 | 501.557 | 341.000 | 340.621 | - | 340.591 |
| Inventories | - | - | 0 | 836 | 5.695 | 11.646 | 41.000 | 41.328 | - | 40.973 |
| Receivables | - | - | 0 | 0 | 540.659 | 400.207 | 296.325 | 297.244 | - | 297.564 |
| Cash | - | - | 44 | 30.129 | 18.300 | 89.704 | 3.675 | 2.048 | - | 2.055 |
| Shareholders Funds | - | - | 44 | 10 | -51.446 | 1.306 | 13.623 | -34.129 | - | -42.416 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | - | 40 |
| Debts | - | - | 0 | 30.955 | 30.356 | 230.196 | 248.126 | 264.559 | - | 273.765 |
| Income in Advance | - | - | 0 | 0 | 585.745 | 573.579 | 552.562 | 554.276 | - | 492.215 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Afine Biofruct Srl